Is a complete PPBT research report available?

No complete published report is available for Purple Biotech Ltd (PPBT) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Purple Biotech Ltd (PPBT)

NASDAQ: PPBT · USD

$1.37

-0.01 (-0.7%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first PPBT analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.1M
Net income (ttm)	-26M
EPS (ttm)	-$0.02
Shares out	1.9B
Volume	3,235.925
Beta	-0.55

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -26M
EPS (ttm): -$0.02
Market cap: 6.1M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All PPBT indicators

Market & fundamental data

Available fields

175

Groups with data

Currency

USD

Showing 175 of 175 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001614744
Company name	Purple Biotech Ltd
Country	Israel
Country code	US
Cusip	74638P307
Employees	10
Employees Change	1%
Employees Change Percent	11.11
Enterprise value	$-407,362
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US74638P3073
Last refreshed	2026-07-31
Market cap	$6.1M
Market cap category	Nano-Cap
Price	$1.37
Price currency	USD
Sector	Healthcare
Sector PE	45.51
Sector PE Fwd	24.23
Sic	2834
Symbol	PPBT
Website	https://purple-biotech.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-426.66%
FCF yield	-111.54%
P/B ratio	0.63x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-59,000
Net Income	$-26M
Net Income Growth Years	1%
Profit Per Employee	$-2.6M
Profitable Quarters	$21
Profitable Years	11
ROA	-19.55
Roa5y	-19.58
ROCE	-288.1
ROE	-123.3
Roe5y	-51.72
ROIC	-22.91

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-56.78%
Cagr1y	-93.55%
Cagr3y	-81.65%
Cagr5y	-73.84%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$14.4M
Cash	$6.4M
Current Assets	$6.8M
Current Liabilities	$4.6M
Debt	$184,000
Debt Equity	$0.02
Equity	$9.7M
Liabilities	$4.8M
Long Term Assets	$7.6M
Long Term Liabilities	$160,000
Net Cash	$6.2M
Net Cash By Market Cap	$102
Net Cash Growth	-10.19%
Net Debt Equity	$-0.65
Tangible Book Value	$2.4M
Tangible Book Value Per Share	$0
WACC	1.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.48
Net Working Capital	$-4.1M
Quick ratio	1.4
Working Capital	$2.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-230.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-99.98%
1Y total return	-93.54%
200-day SMA	4.93
3Y total return	-99.38%
50-day SMA	2.02
50-day SMA vs 200-day SMA	50under200
5Y total return	-99.88%
All Time High	13,900
All Time High Change	-99.99%
All Time High Date	2016-05-16
All Time Low	1.33
All Time Low Change	3.01%
All Time Low Date	2026-07-22
ATR	0.13
Beta	-0.55
Ch YTD	-79.16
High	1.41
High52	24
High52 Date	2025-08-22
High52ch	-94.29%
Low	1.37
Low52	1.33
Low52 Date	2026-07-22
Low52ch	3.01%
Ma50ch	-32.18%
Price vs 200-day SMA	-72.23%
RSI	32.54
RSI Monthly	31.59
RSI Weekly	22.61
Sharpe ratio	-1.46x
Sortino ratio	-2.05
Total Return	-230.28%
Tr YTD	-79.16
Tr1m	-21.26%
Tr1w	-1.44%
Tr3m	-67.61%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.98
Operating Income	$-7.8M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,854,125,531%
Float Percent	99.61%
Net Borrowing	-223,000
Shares Insiders	0.56%
Shares Institutions	17.88%
Shares Out	1,861,354,000
Shares Qo Q	-21.85%
Shares Yo Y	230.28%
Short Ratio	0.27
Short Shares	1.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.1M
Adjusted OCF	-7,108,000
Average Volume	22,671.65x
Bv Per Share	0.01
CAPEX	$-3,000
Ch10y	-99.98
Ch1m	-21.26
Ch1w	-1.44
Ch1y	-93.54
Ch3m	-67.61
Ch3y	-99.38
Ch5y	-99.88
Ch6m	-78.04
Change	-0.72%
Change From Open	-3.04
Close	1.38
Days Gap	2.39
Depreciation Amortization	23,000
Dollar Volume	4,433.2
Earnings Date	2026-08-14
Earnings Time	bmo
EBIT	$-28.3M
EBITDA	$-28.1M
EPS	$-0.02
F Score	1
FCF	$-6.8M
FCF EV Yield	1,669.77x
FCF Per Share	$-0
Financing CF	6,166,000
Fiscal Year End	December
Founded	2,010
Investing CF	420,000
Is Primary Listing	0
Is Spac	No
Last Earnings Date	2026-05-15
Last Report Date	2026-03-31
Last Split Date	2026-03-02
Last Split Type	Reverse
Last10k Filing Date	2026-03-19
Ma150	4.07
Ma150ch	-66.36%
Ma20	1.48
Ma20ch	-7.56%
Net CF	-205,000
Next Earnings Date	2026-08-10
Open	1.41
Optionable	Yes
Position In Range	0
Post Close	1.37
Postmarket Change Percent	2.57
Postmarket Price	$1.41
Ppne	278,000
Price Date	2026-07-30
Ptbv Ratio	2.58
Relative Volume	0.14x
Share Based Comp	309,000
Tr6m	-78.04%
Volume	3,235.9

Purple Biotech Ltd (PPBT)

Coverage state: Market snapshot only — no published research

Generate the first PPBT analysis

Price

Financial snapshot

Fair-value bridge

Latest news · PPBT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All PPBT indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on PPBT

Frequently asked questions